Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. dosikit

DosiKit TERMINATED

DosiKit, a first portable field medical device for fast triage of people after external irradiation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DosiKit project word cloud

Explore the words cloud of the DosiKit project. It provides you a very rough idea of what is the project "DosiKit" about.

final    individuals    specialist    singapore    performed    medical    protected    revenue    2024    ip    expose    publications    device    fto    initial    risk    crisis    collaborations    2014    nrbc    45    experimented    regulatory    validated    potentially    biodosimetry    contact    forecasted    diagnostic    critical    loi    transportable    communications    exercise    irradiation    published    cartography    acubens    commercial    innovative    french    validation    nuclear    partial    2022    technological    fulfil    accident    business    care    international    managers    initiated    requiring    game    founded    emergency    dosimetric    prototype    starting    atomic    actions    armies    responders    minutes    young    israel    radiological    dosikit    hospitals    germany    booster    oral    undergoing    seasoned    bio    changer    continued    irradiated    invented    commercialize    market    giving    exposed    unmet    people    staff    lack    biological    patents    tools    doctors    competencies    scientific    survey    2009    triage    trl6    15    fast    exposure    radiation    energy    instrument    reached    team    schedule    sme    army    pbi    uniting    classify    body    sales    usa    worldwide   

Project "DosiKit" data sheet

The following table provides information about the project.

Coordinator		 ACUBENS 

Organization address
address: 15 RUE PIERRE GILLES DE GENNES
city: NANTERRE
postcode: 92160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACUBENS FR (NANTERRE) coordinator 50˙000.00

Map

 Project objective

Acubens was founded in 2014, to develop and commercialize new game-changer medical diagnostic devices around NRBC emergency. Our team gathers young and experimented doctors, and seasoned business managers, uniting their competencies to develop nuclear/radiological/biological innovative transportable biodosimetry devices. Nuclear/radiological accident can expose individuals to radiation, with the need for fast triage of potentially exposed people requiring immediate medical care. There is today a lack of irradiation biodosimetry tools that can be used in the field, by non-specialist staff, giving immediate results and exposure cartography in case of Partial-Body irradiation (PBI). To fulfil this critical unmet need for better initial crisis management, we invented the DosiKit device and fast test (45 minutes) to identify and classify irradiated individuals, directly in the field. This development was initiated in 2009 by the French Atomic Energy Commission within the European Commission program, BOOSTER (‘BiO-dOSimetric Tools for triagE to Responders’), and then continued by Acubens. DosiKit technology is protected by 3 international patents and has reached TRL6 with a prototype validated in a large-scale exercise performed with the French army. Several collaborations are undergoing for biological validation with French research institute and hospitals. Scientific and technical development was published in 3 scientific publications and many international oral communications. A strong contact has established with French, Germany, Israel, US and Singapore armies (LoI). This DosiKit product will be on the market in 2022, starting in Europe and then extending worldwide. Forecasted sales revenue is 15 M€ in 2024. The objectives of this phase 1 SME-Instrument are: (1) the final Biological and Technological validation of the device, (2) IP, FTO, Regulatory and risk assessment studies and (3) a market survey in Europe and USA to schedule our commercial actions.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DOSIKIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DOSIKIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More